6.
Destere A, Marquet P, Labriffe M, Drici M, Woillard J
. A Hybrid Algorithm Combining Population Pharmacokinetic and Machine Learning for Isavuconazole Exposure Prediction. Pharm Res. 2023; 40(4):951-959.
DOI: 10.1007/s11095-023-03507-y.
View
7.
Poweleit E, Vinks A, Mizuno T
. Artificial Intelligence and Machine Learning Approaches to Facilitate Therapeutic Drug Management and Model-Informed Precision Dosing. Ther Drug Monit. 2023; 45(2):143-150.
PMC: 10378651.
DOI: 10.1097/FTD.0000000000001078.
View
8.
Jelliffe R, Iglesias T, Hurst A, Foo K, Rodriguez J
. Individualising gentamicin dosage regimens. A comparative review of selected models, data fitting methods and monitoring strategies. Clin Pharmacokinet. 1991; 21(6):461-78.
DOI: 10.2165/00003088-199121060-00006.
View
9.
Hsu C, Bansal N
. Measured GFR as "gold standard"--all that glitters is not gold?. Clin J Am Soc Nephrol. 2011; 6(8):1813-4.
DOI: 10.2215/CJN.06040611.
View
10.
De Rosa S, Greco M, Rauseo M, Annetta M
. The Good, the Bad, and the Serum Creatinine: Exploring the Effect of Muscle Mass and Nutrition. Blood Purif. 2023; 52(9-10):775-785.
PMC: 10623400.
DOI: 10.1159/000533173.
View
11.
Sherwin C, Kiang T, Spigarelli M, Ensom M
. Fundamentals of population pharmacokinetic modelling: validation methods. Clin Pharmacokinet. 2012; 51(9):573-90.
DOI: 10.1007/BF03261932.
View
12.
Wallenburg E, Ter Heine R, Schouten J, Raaijmakers J, Ten Oever J, Kolwijck E
. An Integral Pharmacokinetic Analysis of Piperacillin and Tazobactam in Plasma and Urine in Critically Ill Patients. Clin Pharmacokinet. 2022; 61(6):907-918.
PMC: 9249689.
DOI: 10.1007/s40262-022-01113-6.
View
13.
Jelliffe R, Liu J, Drusano G, Martinez M
. Individualized Patient Care Through Model-Informed Precision Dosing: Reflections on Training Future Practitioners. AAPS J. 2022; 24(6):117.
DOI: 10.1208/s12248-022-00769-z.
View
14.
Jelliffe R
. Estimation of creatinine clearance in patients with unstable renal function, without a urine specimen. Am J Nephrol. 2002; 22(4):320-4.
DOI: 10.1159/000065221.
View
15.
Karvaly G, Neely M, Kovacs K, Vincze I, Vasarhelyi B, Jelliffe R
. Development of a methodology to make individual estimates of the precision of liquid chromatography-tandem mass spectrometry drug assay results for use in population pharmacokinetic modeling and the optimization of dosage regimens. PLoS One. 2020; 15(3):e0229873.
PMC: 7058336.
DOI: 10.1371/journal.pone.0229873.
View
16.
Ostermann M, Joannidis M
. Acute kidney injury 2016: diagnosis and diagnostic workup. Crit Care. 2016; 20(1):299.
PMC: 5037640.
DOI: 10.1186/s13054-016-1478-z.
View
17.
Verhaeghe J, Dhaese S, De Corte T, Vander Mijnsbrugge D, Aardema H, Zijlstra J
. Development and evaluation of uncertainty quantifying machine learning models to predict piperacillin plasma concentrations in critically ill patients. BMC Med Inform Decis Mak. 2022; 22(1):224.
PMC: 9404625.
DOI: 10.1186/s12911-022-01970-y.
View
18.
Visibelli A, Roncaglia B, Spiga O, Santucci A
. The Impact of Artificial Intelligence in the Odyssey of Rare Diseases. Biomedicines. 2023; 11(3).
PMC: 10045927.
DOI: 10.3390/biomedicines11030887.
View
19.
Alobaid A, Wallis S, Jarrett P, Starr T, Stuart J, Lassig-Smith M
. Population Pharmacokinetics of Piperacillin in Nonobese, Obese, and Morbidly Obese Critically Ill Patients. Antimicrob Agents Chemother. 2017; 61(3).
PMC: 5328553.
DOI: 10.1128/AAC.01276-16.
View
20.
Jelliffe R, Schumitzky A, Bayard D, Fu X, Neely M
. Describing Assay Precision-Reciprocal of Variance Is Correct, Not CV Percent: Its Use Should Significantly Improve Laboratory Performance. Ther Drug Monit. 2015; 37(3):389-94.
PMC: 4435937.
DOI: 10.1097/FTD.0000000000000168.
View